Supplemental material
Current Medical Research and Opinion
Volume 36, 2020 - Issue 4
Rheumatology
Comparative persistence of anti-tumor necrosis factor therapy in ankylosing spondylitis patients: a multicenter international study
Francisco de Assis Acurcioa Department of Social Pharmacy, School of Pharmacy, Federal University of Minas Gerais (UFMG), Minas Gerais, Brazil;b SUS Collaborating Centre for Technology Assessment and Excellence in Health (CCATES), School of Pharmacy, Federal University of Minas Gerais, Minas Gerais, Brazil;c Department of Social and Preventive Medicine, Post-graduated Program of Public Health, School of Medicine, Federal University of Minas Gerais, Minas Gerais, BrazilCorrespondence[email protected]
https://orcid.org/0000-0002-5880-5261
https://orcid.org/0000-0002-5880-5261, Augusto Afonso Guerra Juniora Department of Social Pharmacy, School of Pharmacy, Federal University of Minas Gerais (UFMG), Minas Gerais, Brazil;b SUS Collaborating Centre for Technology Assessment and Excellence in Health (CCATES), School of Pharmacy, Federal University of Minas Gerais, Minas Gerais, Brazilhttps://orcid.org/0000-0001-5256-0577
https://orcid.org/0000-0001-5256-0577, Michael Ruberson Ribeiro da Silvaa Department of Social Pharmacy, School of Pharmacy, Federal University of Minas Gerais (UFMG), Minas Gerais, Brazil;b SUS Collaborating Centre for Technology Assessment and Excellence in Health (CCATES), School of Pharmacy, Federal University of Minas Gerais, Minas Gerais, Brazilhttps://orcid.org/0000-0003-2550-7249
https://orcid.org/0000-0003-2550-7249, Ramon Gonçalves Pereiraa Department of Social Pharmacy, School of Pharmacy, Federal University of Minas Gerais (UFMG), Minas Gerais, Brazil;b SUS Collaborating Centre for Technology Assessment and Excellence in Health (CCATES), School of Pharmacy, Federal University of Minas Gerais, Minas Gerais, Brazilhttps://orcid.org/0000-0001-7874-3398
https://orcid.org/0000-0001-7874-3398, Brian Godmand Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom;e Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden;f Health Economics Centre, Liverpool University Management School, Liverpool, United Kingdomhttps://orcid.org/0000-0001-6539-6972
https://orcid.org/0000-0001-6539-6972, Marion Bennied Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdomhttps://orcid.org/0000-0002-4046-629X
https://orcid.org/0000-0002-4046-629X, & Elham Rahmeg Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada;h Department of Medicine, Division of Clinical Epidemiology, McGill University, Montreal, Quebec, Canadahttps://orcid.org/0000-0002-4168-4993
https://orcid.org/0000-0002-4168-4993 show all